Literature DB >> 17952558

Genetic counseling for inherited thrombophilias.

Elizabeth A Varga1.   

Abstract

Genetic testing for inherited thrombophilia, including mutation analysis for factor V Leiden and prothrombin G20210A, is commonly performed. Yet, tests for inherited thrombophilia are frequently ordered inappropriately, and without proper counseling about the risks, benefits and limitations of testing. Genetic counselors are uniquely trained to help people understand and adapt to medical, psychological and familial implications of genetic contributions to disease. In the context of thrombophilia, genetic counselors may serve as a resource to other clinicians to: (a) identify individuals and families at increased risk for inherited thrombophilia, (b) offer and explain testing to patients and families, as appropriate, (c) facilitate patient-focused decision-making and informed consent prior to testing, (d) interpret test results, (e) explain inheritance patterns and discuss implications of thrombophilia for family members and (f) provide education and support resources. This article will provide insight into the training and roles of genetic counselors, review indications for thrombophilia testing, and highlight specific issues related to genetic testing, including genetic discrimination concerns.

Entities:  

Mesh:

Year:  2007        PMID: 17952558     DOI: 10.1007/s11239-007-0056-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  17 in total

Review 1.  Diagnostic studies for thrombophilia in women on hormonal therapy and during pregnancy, and in children.

Authors:  Benjamin R Brenner; Ulrike Nowak-Göttl; Andrea Kosch; Marilyn Manco-Johnson; Michael Laposata
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

Review 2.  Clinical utility of factor V leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders.

Authors:  Richard D Press; Kenneth A Bauer; Jody L Kujovich; John A Heit
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

Review 3.  Clinical and laboratory management of the prothrombin G20210A mutation.

Authors:  Ronald C McGlennen; Nigel S Key
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

Review 4.  Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Authors:  O Wu; L Robertson; S Twaddle; G D O Lowe; P Clark; M Greaves; I D Walker; P Langhorne; I Brenkel; L Regan; I Greer
Journal:  Health Technol Assess       Date:  2006-04       Impact factor: 4.014

Review 5.  Familial thrombophilia: genetic risk factors and management.

Authors:  M Makris; F R Rosendaal; F E Preston
Journal:  J Intern Med Suppl       Date:  1997

Review 6.  Communicating genetic risk information.

Authors:  T M Marteau
Journal:  Br Med Bull       Date:  1999       Impact factor: 4.291

Review 7.  Role of the geneticist in testing and counseling for inherited thrombophilia.

Authors:  Laura M Reich; Matthew Bower; Nigel S Key
Journal:  Genet Med       Date:  2003 May-Jun       Impact factor: 8.822

8.  Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?

Authors:  C M Schambeck; S Schwender; I Haubitz; U E Geisen; R E Grossmann; F Keller
Journal:  Thromb Haemost       Date:  1997-12       Impact factor: 5.249

9.  Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception.

Authors:  Benilde Cosmi; Cristina Legnani; Francesco Bernardi; Sergio Coccheri; Gualtiero Palareti
Journal:  Arch Intern Med       Date:  2003-05-12

10.  Knowledge and educational needs of individuals with the factor V Leiden mutation.

Authors:  E A Hellmann; N D Leslie; S Moll
Journal:  J Thromb Haemost       Date:  2003-11       Impact factor: 5.824

View more
  2 in total

Review 1.  Genetic predictors of response to photodynamictherapy.

Authors:  Francesco Parmeggiani; Donato Gemmati; Ciro Costagliola; Francesco Semeraro; Paolo Perri; Sergio D'Angelo; Mario R Romano; Katia De Nadai; Adolfo Sebastiani; Carlo Incorvaia
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

Review 2.  Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.

Authors:  Szilvia Fiatal; Róza Ádány
Journal:  Front Public Health       Date:  2018-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.